discoveri
tn
antigen
mileston
histori
glycosci
unusu
express
among
first
associ
human
disord
tn
syndrom
tn
polyagglutin
syndrom
first
describ
moreau
et
al
observ
unusu
antigen
erythrocyt
patient
rare
acquir
hemolyt
anemia
associ
polyagglutin
erythrocyt
cold
independ
abo
h
bloodgroup
statu
shown
earlier
huebner
also
thomsen
store
erythrocyt
normal
donor
occasion
becom
agglutin
howev
phenomenon
caus
bacteri
glycosidas
neuraminidas
uncov
carbohydr
antigen
scheme
also
term
thomsenfriedenreich
tf
antigen
observ
semin
field
sinc
led
discoveri
neuraminidas
bacterium
vibrio
cholera
sourc
enzym
expos
antigen
could
bound
preexist
antibodi
defin
friedenreich
contrast
tn
syndrom
character
immedi
agglutin
cold
freshli
collect
blood
sampl
agglutin
thought
result
presenc
circul
cold
agglutinin
immunoglobulin
type
tn
antigen
subsequ
shown
truncat
form
major
type
glycosyl
anim
glycoprotein
simpl
structur
scheme
histor
name
tn
antigen
deriv
observ
moreau
et
al
similar
yet
distinct
antigen
henc
design
antigen
nouvel
tn
antigen
cluster
differenti
nomenclatur
tn
antigen
design
sialyl
version
sialyl
tn
disaccharid
antigen
term
dahr
et
al
report
tn
antigen
occur
glycoprotein
human
erythrocyt
cryptic
galnaccontain
antigen
structur
tn
antigen
defin
dahr
et
al
use
gasliquid
chromatographi
show
presenc
serthrlink
galnac
tryptic
glycopeptid
erythrocyt
tnsyndrom
patient
also
show
treatment
glycoprotein
low
concentr
naoh
presenc
sodium
borohydrid
nabh
caus
socal
belimin
reaction
releas
nacetylgalactosaminitol
mani
differ
erythrocyt
membran
glycoprotein
chemic
structur
antigen
disaccharid
eluciglycoprotein
anim
cell
contain
varieti
glycan
structur
ad
coandor
posttransl
protein
differ
type
sugaramino
acid
linkag
known
two
major
type
nglycan
asnlink
oglycan
serthrlink
abnorm
mucintyp
oglycan
whose
express
associ
cancer
sever
human
disord
tn
antigen
rel
simpl
structur
compos
nacetyldgalactosamin
glycosid
linkag
serinethreonin
residu
glycoprotein
one
first
glycoconjug
chemic
synthes
tn
antigen
normal
modifi
specif
galactosyltransferas
tsynthas
golgi
apparatu
cell
express
activ
tsynthas
uniqu
depend
molecular
chaperon
cosmc
encod
gene
x
chromosom
express
tn
antigen
aris
consequ
mutat
gene
tsynthas
cosmc
gene
affect
step
oglycosyl
pathway
associ
tn
antigen
diseas
much
interest
develop
tnbase
vaccin
therapeut
approach
base
tn
express
klenk
uhlenbruck
interestingli
disaccharid
determin
first
demonstr
studi
human
brain
gangliosid
exampl
nonsialyl
contain
termin
howev
galnac
brather
alink
case
thu
distinguish
antigen
chemic
synthesi
tn
antigen
link
lserin
lthreonin
first
describ
kaifu
osawa
subsequ
sever
group
includ
lemieux
cowork
paulsen
group
took
differ
synthet
approach
eleg
strategi
tnantigen
synthesi
devis
paulsen
pioneer
use
nonparticip
azido
group
galnac
donor
thu
chlorid
underw
koenigsknorr
type
reaction
nbenzyloxycarbonyl
deriv
serin
threonin
presenc
silver
carbon
silver
perchlor
promot
form
anom
stereoselect
scheme
azido
group
convert
reduct
acetyl
natur
occur
acetamid
group
protect
ester
cleav
gener
respect
similar
reaction
fmoc
deriv
ser
thr
describ
later
kunz
birnbach
use
halo
donor
promot
highli
select
aglycosyl
reaction
gener
disaccharid
antigen
azido
group
first
product
scheme
reduc
sugar
select
odeacetyl
benzyliden
give
deriv
react
tetraoacetyladgalactosylpyranosyl
bromid
yield
disaccharid
subsequ
remov
protect
group
provid
nacetyl
galgalnacserthr
build
block
anoth
eleg
synthesi
tn
antigen
scheme
b
involv
use
acetyl
thiophenyl
donor
ph
sotf
promot
system
promot
effici
stereoselect
glycosyl
fmocthr
oh
obn
fmocser
oh
obn
specif
gener
aglycosid
modern
synthes
glycopeptid
contain
tn
antigen
conduct
variou
strategi
interest
solidphas
synthet
approach
glycosyl
trichloroacetimid
use
stereoselect
modifi
ser
thr
hydroxi
group
resinbound
peptid
develop
peptid
singl
multipl
tn
antigen
mani
techniqu
glycopeptid
synthesi
util
n
fmocthr
aco
adgalnac
correspond
ser
deriv
commerci
avail
furthermor
glycopeptid
tn
antigen
may
also
chemoenzymat
gener
use
synthet
peptid
acceptor
glycosyltransferas
transfer
galnac
serthr
residu
strategi
import
develop
potenti
vaccin
tn
antigen
discuss
section
tn
antigen
occur
abund
normal
cell
tissu
adult
anim
evid
oncofet
antigen
year
varieti
approach
use
detect
tn
antigen
approach
advantag
limit
may
broadli
subdivid
three
categori
chemic
lectinbas
antibodybas
direct
chemic
approach
typic
involv
belimin
strategi
nacetylgalactosaminitol
gener
alkalin
degrad
glycopeptid
presenc
nabh
simultan
modif
link
amino
acid
ser
acid
dehydroalanin
thr
acid
identif
nacetylgalactosaminitol
ga
chromatographi
follow
acetyl
often
associ
detect
modifi
ser
thr
amino
acid
taken
chemic
evid
presenc
tn
antigen
glycopeptid
glycoprotein
although
approach
appropri
suffici
amount
materi
avail
difficult
perform
type
analysi
small
amount
present
cell
tissu
variat
strategi
use
galactos
oxidas
without
prior
neuraminidas
treatment
oxid
potenti
nonreduc
termin
galnac
residu
tn
antigen
hydroxi
group
reduc
radiolabel
nab
h
presenc
radiolabel
galnac
indic
tn
antigen
cours
radiolabel
gal
also
produc
nonsialyl
antigen
present
howev
histor
domin
strategi
detect
tn
antigen
lectinand
antibodybas
huge
number
differ
galnacbind
lectin
plant
anim
use
explor
express
tn
antigen
lectin
use
includ
plant
lectin
dolicho
bifloru
agglutinin
dba
marrubium
candidissimum
agglutinin
maclura
pomifera
lectin
mpl
salvia
horminum
agglutinin
sha
salvia
sclarea
agglutinin
ssa
salvia
bogotensi
lectin
artocarpu
integrifolia
lectin
jacalin
bauhinia
purpurea
agglutinin
bpa
isolectin
vicia
villosa
agglutinin
soja
hispida
lectin
moluccella
laevi
lectin
mll
snailderiv
helix
pomatia
agglutinin
hpa
absenc
bind
lectin
also
use
explor
potenti
express
tnstn
antigen
stn
antigen
sialyltn
antigen
thr
exampl
springer
et
al
show
erythrocyt
patient
tn
syndrom
diminish
bind
lectin
vicia
graminea
arachi
hypogoea
peanut
agglutinin
pna
bind
sialic
acid
antigen
respect
furthermor
tnexpress
cell
line
jurkat
leukem
cell
human
colon
carcinoma
lsc
cell
bind
well
hpa
bind
well
pna
even
desialyl
behavior
consist
express
tn
antigen
cell
two
common
plant
lectin
use
explor
tn
express
hpa
exampl
use
explor
express
tn
antigen
mani
differ
cancer
cell
includ
pancrea
breast
lung
prostat
hpa
wide
use
sinc
earli
studi
tnantigen
express
exampl
clonal
express
tn
antigen
blood
cell
establish
vainchenk
et
al
use
fluoresc
label
hpa
show
express
tn
antigen
erythroid
granulocyt
cell
coloni
deriv
patient
tn
syndrom
tn
express
platelet
patient
tn
syndrom
also
studi
use
bind
hpa
along
galactos
oxidasenab
h
reduct
identifi
tn
express
platelet
glycoprotein
gpib
howev
use
hpa
identifi
tnantigen
express
problemat
hpa
also
bind
cad
antigen
blood
group
antigen
forssman
glycolipid
gener
plant
anim
lectin
bind
galnac
crossreact
nonreduc
termin
galnac
residu
either
aor
blink
seen
also
bind
cad
sda
antigen
thu
studi
lectin
use
defin
express
tn
antigen
carri
cautious
evid
supplement
corrobor
chemic
immunolog
andor
geneticmolecular
data
one
earliest
immunolog
approach
detect
tn
antigen
base
antitn
antisera
gener
natur
upon
recognit
antigen
springer
research
group
use
human
antitn
antibodi
occur
peopl
reagent
tn
identif
follow
observ
small
level
antitn
antibodi
occur
sera
peopl
format
circul
antitn
antibodi
shown
partli
due
exposur
enterobacteriacea
express
tn
antigen
springer
tegtmey
show
sera
white
leghorn
chick
grown
germfre
environ
contain
antitn
antibodi
wherea
chick
grown
normal
hatcheri
express
antibodi
moreov
feed
germfre
chick
bacteria
express
tn
antigen
elicit
format
antitn
antibodi
inhal
ingest
bacteria
express
tn
antigen
human
infant
adult
also
caus
express
circul
antitn
antibodi
springer
et
al
defin
immunogen
tn
antigen
part
studi
human
blood
group
mn
antigen
discov
tn
antigen
express
carcinomaassoci
antigen
human
tumor
cell
report
develop
first
time
murin
monoclon
antibodi
mab
tn
antigen
shortli
thereaft
first
murin
mab
sialyltn
antigen
gener
hakomori
cowork
use
mab
shown
tn
sialyltn
antigen
coexpress
erythrocyt
patient
tn
syndrom
present
signific
extent
erythrocyt
control
donor
hakomori
cowork
also
develop
sever
mab
tn
antigen
immun
mice
lungcarcinoma
cell
screen
histolog
hybridoma
made
mab
tumortissu
specimen
problem
use
differ
mab
tn
antigen
specif
antibodi
mab
tn
antigen
clearli
crossreact
galnaccontain
glycan
blood
group
antigen
exampl
use
antir
cum
et
al
wwwangewandteorg
tn
monoclon
antibodi
refer
mab
appear
specif
crossreact
blood
group
antigen
one
use
mous
antitn
mab
igm
clone
origin
develop
springer
cowork
use
wide
immunohistochemistri
flow
cytometri
detect
tn
antigen
follow
death
dr
springer
assist
herta
tegtmey
ship
stock
purifi
mab
includ
abovement
igm
tn
antigen
cum
laboratori
unfortun
hybridoma
springer
laboratori
lost
earlier
howev
sampl
mab
tn
antigen
obtain
upon
request
cum
research
group
use
other
exampl
studi
tnantigen
express
drosophila
use
mous
antistn
mab
immunoglobulin
clone
commerci
obtain
sever
sourc
includ
dakocytom
addit
mab
tn
antigen
sialyltn
antigen
commerci
avail
sever
sourc
tn
antigen
glycoprotein
synthes
famili
enzym
polypeptid
anacetylgalactosaminyltransferas
ppgalnact
transfer
galnac
unit
donor
udpgalnac
ser
thr
residu
protein
scheme
process
first
step
biosynthesi
mucintyp
oglycan
estim
uniqu
ppgalnact
gene
occur
human
genom
mice
human
gene
locat
chromosom
ppgalnact
transmembran
protein
consist
amino
acid
thu
larger
glycosyltransferas
transferas
activ
locat
ntermin
domain
ctermin
domain
contain
rtype
lectin
domain
although
ppgalnact
ec
seem
catalyz
gener
reaction
express
ppgalnact
isoform
isozym
tissuespecif
adult
mammal
ppgalnact
display
distinct
yet
overlap
substrat
prefer
activ
ppgalnact
except
appear
enhanc
pro
residu
posit
rel
serthr
pro
residu
posit
enhanc
activ
variou
degre
depend
ppgalnact
isoform
ctermin
rtype
lectin
domain
homolog
lectin
domain
ricin
recogn
bind
carbohydr
suggest
catalyt
lectin
domain
ppgalnact
function
concert
direct
select
glycosyl
site
propos
agreement
hierarch
addit
core
galnac
residu
protein
mucin
exampl
protein
compos
amino
acid
whose
molecular
mass
increas
million
da
addit
hundr
oglycan
extrem
effici
oglycosyl
due
high
activ
ppgalnact
wide
distribut
along
golgi
apparatu
epitheli
cell
also
lectin
domain
bind
previous
form
glycan
rtype
lectin
domain
enabl
enzym
slide
along
protein
thu
effici
attach
galnac
one
serthr
residu
anoth
ppgalnact
local
golgi
apparatu
shown
hela
cell
henc
presum
act
fold
protein
exit
correctli
endoplasm
reticulum
er
follow
format
golgi
apparatu
tn
antigen
serv
acceptor
least
three
golgi
glycosyltransferas
core
core
tsynthas
synthes
core
structur
antigen
core
core
synthes
core
structur
sialyltransferas
synthes
sialyltn
antigen
scheme
common
modif
tn
antigen
format
core
disaccharid
action
tsynthas
key
enzym
mucintyp
oglycan
biosynthesi
express
cell
human
mice
scheme
core
glycan
usual
either
sialyl
yield
sialylt
antigen
sialyl
iv
yield
disialylt
antigen
altern
core
oglycan
disaccharid
modifi
core
oglycan
elong
form
extend
core
oglycan
branch
core
form
core
oglycan
core
structur
mostli
found
gastrointestin
tract
usual
elong
form
complex
core
oglycan
express
high
level
bovin
submaxillari
gland
hardli
found
tissu
therefor
stn
detect
normal
tissu
submaxillari
gland
cow
sheep
form
stn
termin
structur
acceptor
glycosyltransferas
major
enzym
modifi
tn
antigen
normal
tissu
udpgal
glycopeptid
core
tsynthas
tsynthas
transfer
gal
donor
udpgal
presenc
dival
cation
glycoprotein
format
bglycosid
bond
form
core
structur
antigen
thu
tsynthas
invert
glycosyltransferas
sinc
form
b
linkag
alink
gal
residu
donor
udpgal
enzym
assay
origin
bhk
cell
homogen
crude
prepar
pig
rat
colon
mucosa
partli
purifi
form
rat
liver
enzym
purifi
homogen
rat
liver
purifi
enzym
kda
disulfidebound
homodim
kda
monom
observ
activ
well
reason
two
homodim
form
differ
molecular
mass
unclear
basi
ntermin
sequenc
rat
tsynthas
cdna
human
tsynthas
clone
encod
amino
acid
aa
typeii
transmembran
protein
northernblot
analysi
reveal
two
differ
transcript
human
tsynthas
size
kb
transcript
kb
probabl
matur
activ
form
kb
transcript
found
rat
test
whether
transcript
larger
size
incomplet
splice
form
function
unclear
orthologu
variou
speci
includ
chimpanze
cow
dog
rat
mous
bird
frog
zebra
fish
well
invertebr
drosophila
c
elegan
either
clone
identifi
align
protein
sequenc
high
homolog
especi
mammalian
protein
observ
tsynthas
uniqu
share
minim
homolog
conserv
motif
remark
singl
gene
tsynthas
human
mammal
human
gene
resid
chromosom
consist
three
exon
second
exon
largest
interestingli
mammalian
tsynthas
nglycosyl
unlik
glycosyltransferas
contain
nglycosyl
site
primari
amino
acid
sequenc
contrast
tsynthas
c
elegan
drosophila
contain
nglycosyl
site
even
though
singl
function
gene
tsynthas
human
blast
homolog
search
reveal
four
highli
homolog
dna
sequenc
relat
chromosom
term
sequenc
human
pseudogen
respect
see
support
inform
sequenc
align
contrast
function
gene
consist
singl
exon
mani
missens
mutat
dnafrag
delet
sequenc
chromosom
conserv
exhibit
ident
cdna
chromosom
ident
cdna
chromosom
ident
cdna
first
base
match
exon
bp
account
major
overal
differ
chromosom
least
conserv
homolog
function
gene
lack
first
approxim
bp
end
r
cum
et
al
exon
bp
portion
exon
ii
mutat
delet
four
pseudogen
result
mani
stop
codon
openreadingfram
orf
shift
lead
nonorf
dna
sequenc
neither
revers
complementari
sequenc
pseudogen
contain
orf
indic
gene
part
gene
suggest
pseudogen
search
human
express
sequenc
tag
est
databas
gave
three
hit
perfectli
match
two
match
match
indic
chromosom
respect
probabl
transcript
activ
certain
tissu
given
similar
four
pseudogen
human
like
chromosom
evolutionarili
oldest
wherea
chromosom
recent
singleexon
natur
pseudogen
suggest
result
revers
transcript
mrna
human
subsequ
integr
human
genom
exist
four
nonfunct
gene
may
testifi
evolut
human
may
also
import
regul
human
express
particularli
pseudogen
appear
transcript
activ
besid
tsynthas
two
wellknown
glycosyltransferas
also
use
tn
antigen
acceptor
core
scheme
cmpneuac
glycopeptid
transfer
sialic
acid
acid
cmp
cytidin
monophosph
gener
stn
antigen
human
encod
gene
belong
human
famili
six
member
differ
acceptorsubstr
specif
act
tn
antigen
antigen
sialylt
antigen
mainli
act
core
oglycan
form
antigen
scheme
although
one
studi
show
ii
could
sialyltn
synthas
other
demonstr
major
enzym
respons
sialyltn
format
human
tumor
interestingli
studi
show
transcript
upregul
immort
b
cell
patient
iga
nephropathi
clearli
much
need
done
clarifi
role
enzym
stn
format
udpglcnac
glycopeptid
core
catalyz
transfer
glcnac
udpglcnac
tn
antigen
form
core
structur
human
locat
chromosom
express
restrict
mucussecret
tissu
level
express
variou
human
tissu
measur
realtim
pcr
reveal
highest
stomach
follow
colon
small
intestin
oglycan
includ
core
core
primari
compon
intestin
mucu
layer
cover
gastrointestin
epithelium
mucu
layer
dens
carbohydraterich
matrix
consist
primarili
mucin
contain
multipl
serin
threonin
residu
modifi
oglycan
account
mucin
mass
mucu
layer
epitheli
cell
form
intestin
barrier
protect
epitheli
intestin
mucos
immun
cell
potenti
harm
lumin
microflora
food
compon
gener
activ
tsynthas
core
galactosyltranferasespecif
molecular
chaperon
abbrevi
cosmc
requir
format
activ
tsynthas
vivo
human
cosmc
encod
singl
exon
gene
contrast
tsynthas
found
vertebr
invertebr
cosmc
orthologu
occur
vertebr
cosmc
first
partial
copurifi
tsynthas
rat
liver
display
appar
molecular
mass
sdspage
kda
similar
size
tsynthas
basi
protein
sequenc
kb
cdna
clone
could
predict
orf
encod
amino
acid
typeii
transmembran
protein
demonstr
cosmc
local
endoplasm
reticulum
er
function
chaperon
fold
tsynthas
discuss
section
mention
section
human
tleukem
jurkat
cell
line
express
tn
antigen
jurkat
cell
defici
tsynthas
activ
therefor
gener
primarili
tn
antigen
lack
larger
mucintyp
oglycan
tsynthas
gene
transcript
normal
jurkat
cell
cosmc
cdna
mutat
contain
insert
posit
result
orf
shift
prematur
stop
codon
introduct
function
wildtyp
cosmc
jurkat
cell
restor
tsynthas
activ
also
correct
oglycan
structur
cellsurfac
glycoprotein
recent
engin
mice
complet
partial
delet
cosmc
similar
human
gene
mous
cosmc
singleexon
gene
x
chromosom
anim
complet
major
loss
cosmc
die
embryo
day
embryon
develop
robust
express
tn
antigen
virtual
everi
identifi
cell
mice
partial
delet
cosmc
exhibit
variabl
phenotyp
depend
extent
delet
sex
wherebi
male
mice
surviv
much
rare
femal
mice
owe
xchromosom
locat
cosmc
observ
tn
stn
antigen
mani
tn
antigen
tissu
stomach
intestin
kidney
liver
spleen
lung
pancrea
confirm
cosmc
requir
tsynthas
function
cosmc
orthologu
high
homolog
human
cosmc
found
mani
vertebr
includ
chimpanze
cow
mous
rat
dog
bird
frog
zebra
fish
unlik
mammalian
cosmc
protein
compris
amino
acid
rodent
cosmc
contain
amino
acid
sequenc
ident
human
protein
lack
two
amino
acid
posit
human
sequenc
order
two
amino
acid
locat
begin
lumin
ctermin
domain
account
function
cosmc
appear
influenc
local
endoplasm
reticulum
inde
mous
cosmc
function
well
human
cosmc
promot
human
mous
tsynthas
activ
contrast
vertebr
invertebr
c
elegan
drosophila
cosmc
orthologu
howev
tsynthas
express
vertebr
invertebr
wherea
vertebr
tsynthas
lack
conserv
nglycosyl
site
invertebr
tsynthas
multipl
nglycosyl
site
may
therefor
vertebr
cosmc
compens
failur
nonnglycosyl
tsynthas
recogn
fold
calnexincalreticulin
system
endoplasm
reticulum
er
contrast
invertebr
tsynthas
multipl
nglycosyl
site
may
requir
cosmc
fold
control
format
activ
protein
human
cosmc
share
approxim
sequenc
ident
tsynthas
contribut
origin
misidentif
anoth
tsynthas
mistak
subsequ
correct
homolog
mostli
concern
lumin
domain
six
cystein
residu
suggest
cosmc
may
evolv
tsynthas
two
protein
common
origin
indirect
evid
come
four
pseudogen
human
tsynthas
chromosom
like
cosmc
found
singleexon
gene
therefor
appear
cosmc
may
evolv
tsynthas
pseudogen
clear
two
major
mechan
express
tn
antigen
result
genet
chang
lead
decreas
express
either
function
cosmc
andor
tsynthas
howev
possibl
factor
could
influenc
oglycosyl
pathway
describ
lead
express
tn
antigen
decreas
express
synthes
core
structur
gastrointestin
tract
lead
tnstn
express
loss
associ
colon
cancer
chines
hamster
ovari
cho
cell
lack
transport
udpgal
socal
cell
line
lack
galactos
residu
nand
oglycan
consequ
synthes
tn
antigen
krieger
cowork
isol
cho
cell
line
lack
udpglcglcnac
cell
term
ldld
cell
thu
unabl
synthes
udpgal
udpgalnac
unless
suppli
exogen
galgalnac
glycoprotein
contain
galgalnac
absenc
ad
galactos
ldld
cell
synthes
glycoprotein
lack
galactos
thu
express
truncat
nglycan
well
tnantigen
oglycan
therefor
nucleotid
sugar
udpgal
udpgal
transport
essenti
synthesi
normal
oglycan
lack
tn
antigen
defect
biosynthet
transport
pathway
lead
abnorm
tn
express
furthermor
overexpress
lead
product
sialyltn
antigen
commonli
found
colon
breast
tumor
result
competit
endogen
tsynthas
final
possibl
normal
oglycan
could
degrad
expos
tn
antigen
exampl
antigen
convert
tn
antigen
treatment
bovin
testicular
bdgalactosidas
thu
cell
tn
andor
stn
antigen
express
import
defin
pathway
express
biochem
genet
biosynthesi
tsynthas
er
cosmc
predict
bind
newli
synthes
tsynthas
prevent
aggreg
subsequ
degrad
erassoci
degrad
erad
proteasom
pathway
figur
cell
lack
cosmc
tsynthas
still
synthes
truncat
n
terminu
misfold
bound
er
bip
bind
protein
major
chaperon
er
also
call
kda
glucoseregul
protein
perhap
chaperon
bind
misfold
protein
misfold
tsynthas
retrotransloc
cytosol
polyubiquitin
subsequ
degrad
proteasom
without
cosmc
tsynthas
appear
within
larg
disulfidelink
oligomer
complex
inact
trap
within
lumen
er
process
separ
retrotransloc
inact
tsynthas
er
cytoplasm
ubiquitin
inact
tsynthas
target
destruct
poorli
understood
treatment
cell
proteasom
inhibitor
lead
accumul
inact
tsynthas
protein
aggreg
interestingli
inact
tsynthas
coimmunoprecipit
er
chaperon
bind
expos
hydrophob
region
misfold
protein
howev
bind
tsynthas
er
chaperon
lead
correct
fold
presenc
function
cosmc
chaperon
remain
essenti
recent
studi
shown
recombin
tsynthas
denatur
heat
treatment
guanidinium
hydrochlorid
reacquir
activ
vitro
incub
recombin
cosmc
absenc
protein
factor
bind
hydrolysi
adenosin
atp
affect
renatur
process
find
interest
sinc
cosmc
shown
bind
atp
suggest
atp
may
role
vivo
cosmc
interact
function
clearli
much
r
cum
et
al
learn
biolog
role
cosmc
need
specif
chaperon
tsynthas
deriv
tnantigen
precursor
surpris
express
tn
antigen
patholog
indic
sinc
tn
antigen
precursor
mani
import
complex
oglycan
complex
oglycan
usual
extend
structur
base
core
core
oglycan
found
numer
cellsurfac
glycoprotein
glycoprotein
contain
core
oglycan
includ
lowdensitylipoprotein
ldl
receptor
transferrin
receptor
glycophorin
podoplanin
endoglycan
zona
pellucida
glycoprotein
trail
receptor
famili
neurotrophin
receptor
muc
famili
mucin
membranebound
secret
platelet
glycoprotein
gpiba
platelet
integrin
gpiibiiia
core
oglycan
also
found
mani
secret
serum
glycoprotein
includ
human
igd
erythropoietin
von
willebrand
factor
vwf
blood
coagul
factor
x
serum
apociii
human
chorion
gonadotropin
hcg
tammhorsfal
glycoproteinuromodulin
gc
macrophag
activ
factor
gcmaf
natur
deriv
form
human
vitamin
bind
protein
human
urinari
thrombomodulin
human
milk
bilesaltstimul
lipas
furthermor
oglycan
found
virtual
mucin
secret
epitheli
cell
surfac
anim
cell
includ
erythrocyt
thu
reason
conclud
core
oglycan
express
mammalian
cell
found
mani
membran
secret
glycoprotein
alter
express
oglycan
mani
glycoprotein
list
associ
molecular
chang
glycoprotein
molecular
chang
often
associ
turn
chang
cellular
signal
metabol
receptor
function
thu
express
tn
antigen
glycoprotein
may
lead
reflect
alter
function
one
bestunderstood
function
core
oglycan
selectin
recognit
especi
bind
pselectin
glycoprotein
ligand
p
l
eselectin
human
mucin
repeat
mucin
motif
contain
sialyl
lewi
x
sle
x
antigen
core
oglycan
glycan
common
one
extrem
n
terminu
along
adjac
sulfat
tyrosin
residu
serv
key
carbohydr
recognit
ligand
pand
lselectin
wherea
eselectin
bind
depend
sulfat
thu
loss
oglycan
biosynthet
pathway
result
loss
tsynthas
cosmc
would
lead
loss
function
ligand
leukocyt
addit
extend
core
oglycan
express
special
endotheli
cell
within
high
endotheli
venul
also
contain
sulfat
glcnac
residu
within
sle
x
motif
x
loss
fucosyl
residu
lead
loss
function
recognit
lselectin
circul
leukocyt
compromis
lymphocyt
home
recircul
thu
pathway
regul
tsynthas
synthesi
core
extend
core
core
oglycan
essenti
leukocyt
traffick
inflammatori
respons
express
tn
antigen
blood
cell
expect
biolog
consequ
inflamm
thrombosi
hemostasi
potenti
role
oglycan
vascular
format
includ
angiogenesi
lymphangiogenesi
clear
shown
delet
tsynthas
gene
mice
express
tn
antigen
caus
failur
angiogenesi
lymphangiogenesi
interestingli
lack
tsynthas
endotheli
hematopoiet
left
cosmc
express
endoplasm
reticulum
bind
newli
synthes
tsynthas
assist
fold
enzym
acquisit
activ
dimer
tsynthas
move
golgi
apparatu
function
add
galactos
residu
donor
udpgal
tnantigen
precursor
oglycan
normal
oglycan
may
sialyl
gener
sialyl
core
oglycan
may
elong
extend
core
structur
core
oglycan
see
scheme
right
absenc
function
cosmc
newli
synthes
tsynthas
er
misfold
retrotransloc
cytoplasm
ubiquitin
degrad
proteasom
lack
function
tsynthas
golgi
apparatu
lead
express
tn
sialyltn
antigen
cell
surfac
secret
glycoprotein
cell
caus
misconnect
blood
lymphat
vessel
observ
indic
import
role
oglycan
lymphaticvessel
develop
lymphangiogenesi
although
precis
mechanist
role
oglycan
yet
defin
shown
delet
heavili
oglycosyl
glycoprotein
podoplanin
contain
dozen
oglycan
lack
nglycan
phenocopi
phenotyp
mice
defici
gene
tsynthas
interestingli
partial
loss
tsynthas
mice
result
phenotyp
thrombocytopenia
kidney
diseas
distort
glomerulartubular
architectur
renal
lesion
along
progress
proteinuria
prematur
death
precis
patholog
consequ
tn
express
angiogenesi
lymphangiogenesi
unknown
howev
may
dualli
caus
loss
glycoprotein
function
truncat
oglycan
well
recognit
tn
antigen
host
immun
cell
patholog
cellcel
interact
discuss
section
characterist
mucos
epitheli
cell
product
mucin
oglycosyl
glycoprotein
whose
express
often
alter
differ
cancer
least
differ
mucin
gene
identifi
lack
tandem
repeat
although
relat
sequenc
share
featur
repeat
motif
rich
serthrpro
residu
contain
larg
amount
oglycan
mucin
contain
aa
residu
singl
polypeptid
largest
allel
porcin
submaxillari
mucin
encod
protein
aa
sever
mucin
bodi
fluid
epitop
studi
tumor
marker
clone
gene
encod
tumor
marker
show
gene
sever
mucin
studi
regard
tnandor
stnantigen
express
cancer
figur
highli
express
mani
breast
ovarian
type
carcinoma
associ
express
tn
stn
antigen
breast
colorect
hepatocellular
carcinoma
neoplasm
relat
studi
also
shown
express
tnstn
well
mucin
differ
carcinoma
discuss
section
number
research
group
attempt
use
inform
synthesi
mucinbas
glycopeptid
vaccin
target
tumor
express
epitop
tumor
colon
mucin
carri
type
tumorassoci
carbohydr
antigen
includ
sle
x
sialyl
lewi
newman
uhlenbruck
observ
bovin
fat
globul
membran
glycoprotein
bound
antitn
serum
hpa
contain
tn
antigen
contrast
human
fat
globul
membran
glycoprotein
bound
hpa
bovin
submaxillari
mucin
bsm
also
contain
consider
amount
tn
sialyltn
antigen
thu
bovin
fat
globul
membran
glycoprotein
bsm
rare
exampl
glycoprotein
mammal
tn
antigen
may
occur
natur
glycoprotein
neither
link
cancer
anoth
disord
tn
syndrom
common
pathway
mucin
glycosyl
cell
gener
core
oglycan
follow
elong
modif
core
oglycan
inde
transcript
tsynthas
found
cell
tissu
notabl
except
biosynthesi
core
oglycan
mucin
gastrointestin
tract
transcript
specif
express
thu
compromis
express
tsynthas
lead
elev
express
tnstn
antigen
mucin
wide
varieti
cell
wherea
much
known
function
oglycan
especi
core
core
oglycan
membran
glycoprotein
littl
realli
known
specif
typic
mucin
contain
larg
number
ser
thr
pro
residu
backbon
polypeptid
abund
modif
normal
mucin
residu
modifi
contain
differ
core
glycan
shown
scheme
howev
upon
cellular
transform
modif
may
compromis
cell
may
gener
tumorassoci
mucin
contain
tumorassoci
carbohydr
antigen
taca
tn
sialyltn
one
mechan
express
tn
sialyltn
antigen
mucin
loss
function
chaperon
cosmc
figur
factor
could
also
lead
elev
express
taca
discuss
text
function
glycan
muc
gene
product
normal
biolog
suggest
cancer
oglycan
larg
mucin
may
antiadhes
function
thu
indirectli
support
tumorcel
metastasi
favor
detach
cell
extracellular
matrix
ecm
overexpress
interfer
integrinmedi
adhes
ecm
altern
glycosyl
muc
epiglycanin
may
lead
mask
tumor
cellsurfac
antigen
immun
system
recogn
cell
tumor
prolifer
therefor
promot
loss
engin
mice
lead
decreas
express
suscept
coliti
colorect
cancer
observ
indic
mucin
glycosyl
may
barrier
protect
function
howev
disturb
know
littl
specif
requir
biolog
role
distinct
glycan
structur
core
versu
core
larg
mucin
airway
mucin
glycosyl
alter
diseas
condit
may
contribut
case
patient
cystic
fibrosi
enhanc
adhes
biofilm
format
pneumoniacaus
pathogen
pseudomona
aeruginosa
although
oglycan
may
recogn
pathogen
case
normal
physiolog
function
specif
glycan
speci
mucin
well
understood
tn
syndrom
rare
hematolog
disord
subpopul
blood
cell
lineag
carri
tn
antigen
describ
section
patient
tn
syndrom
tn
antigen
first
discov
clinic
patient
usual
appear
healthi
requir
treatment
laboratori
test
may
uncov
moder
hemolyt
anemia
reduc
number
thrombocyt
leukocyt
dahr
et
al
report
reduc
amount
sialic
acid
galactos
erythrocyt
glycoprotein
patient
tn
syndrom
led
exposur
galnac
alink
hydroxi
group
serin
threonin
postul
exposur
agalnac
might
due
defect
galactosyltransferas
blood
cell
lineag
affect
mani
cell
normal
defect
probabl
aros
somat
mutat
pluripotentstemcel
level
interestingli
bird
suggest
tn
antigen
form
spontan
patient
tn
syndrom
somat
mutat
suggest
came
respons
question
springer
regard
bird
present
specif
plant
agglutinin
erythrocyt
membran
antigen
annual
meet
new
york
academi
scienc
definit
structur
tn
antigen
truncat
form
antigen
propos
bird
cowork
express
due
defect
bgalactosyltransferas
cell
express
tn
antigen
patient
tn
syndrom
note
platelet
tnsyndrom
patient
platelet
express
tn
antigen
exhibit
defect
glycosyl
platelet
glycoprotein
gpib
find
correl
thrombocytopenia
observ
individu
fact
substanti
number
tcell
clone
patient
affect
tn
syndrom
later
shown
devoid
tsynthas
activ
underli
genet
chang
turn
somat
mutat
cosmc
summar
tabl
mutat
either
caus
orf
shift
andor
stop
codon
caus
cosmc
gene
transcrib
result
total
sever
impair
chaperon
function
fact
immort
leukocyt
patient
tabl
transcript
cosmc
probabl
due
chang
promot
region
thurnher
et
al
hypothes
chang
may
hypermethyl
promot
region
modif
explain
suppress
gene
tsynthas
tnsyndrom
patient
would
thu
interest
examin
whole
cosmc
gene
immort
leukocyt
patient
see
whether
loss
transcript
due
mutat
hypermethyl
promot
mechan
occasion
lead
hemolyt
anemia
reduc
thrombocyt
leukocyt
count
patient
tn
syndrom
appear
multifactori
fulli
understood
howev
like
autoantibodi
direct
tn
antigen
form
antibodi
may
igm
cold
agglutinin
type
shown
autoantibodi
carbohydr
larg
antigen
present
adult
erythrocyt
termin
alink
galnac
human
tumor
cell
first
describ
basi
observ
cell
bound
agglutinin
snaillectin
hpa
recogn
tn
antigen
springer
et
al
report
tn
test
indic
stop
codon
tn
antigen
antigen
present
high
level
around
breast
carcinoma
cumul
studi
show
cancer
colon
lung
bladder
cervix
ovari
stomach
prostat
express
tn
antigen
contrast
littl
express
observ
normal
adult
tissu
mani
cancer
includ
cervic
cancer
lung
adenocarcinoma
colorect
carcinoma
breast
carcinoma
gastric
carcinoma
tnantigen
express
correl
metastat
potenti
poor
prognosi
express
sialyltn
antigen
also
often
observ
mani
human
cancer
could
also
aris
multipl
mechan
like
mechan
enhanc
express
sialyltn
antigen
increas
express
activ
enzym
also
form
sialyltn
antigen
vitro
may
import
vivo
form
altern
sialyl
structur
scheme
truncat
oglycan
cancer
mucin
may
also
aris
chang
rel
express
core
mechan
link
tnantigen
express
cancer
progress
start
understood
tn
antigen
present
colon
carcinoma
cell
found
bound
macrophag
galactosetyp
lectin
mgl
express
macrophag
dendrit
cell
see
also
section
mgl
express
human
immatur
dendrit
cell
particularli
tolerogen
dendrit
cell
tnantigen
bind
may
lead
immunosuppress
effect
enabl
tumor
escap
immunosurveil
addit
hypothes
analog
observ
regard
lowdensitylipoprotein
ldl
receptor
transferrin
receptor
pselectin
glycoprotein
dystroglycan
incomplet
oglycosyl
receptor
present
cancer
cell
may
impair
express
andor
biolog
activ
consequ
prolifer
control
adhes
properti
cancer
cell
may
alter
one
molecular
basi
tnantigen
express
human
tumor
cell
recent
shown
loss
function
cosmc
exposur
tn
antigen
two
specimen
human
cervic
carcinoma
well
colon
cancer
melanomaderiv
cell
line
due
either
somat
mutat
cosmc
absenc
cosmc
transcript
tabl
consist
find
human
tumor
mous
fibrosarcoma
express
tn
antigen
result
delet
aa
posit
within
lumin
domain
cosmc
mous
neuroblastoma
cell
line
also
known
tnposit
cosmc
contain
mutat
result
prematur
stop
codon
discoveri
somat
cosmc
mutat
cancer
cell
first
exampl
found
regul
global
express
tumorspecif
carbohydr
antigen
singl
genet
locu
divers
type
human
neoplast
diseas
remark
dahr
et
al
wrote
tempt
specul
pathogen
mechan
may
lead
gener
tn
antigen
tumor
tn
syndrom
specul
shown
true
year
later
common
pathogen
mechan
lossoffunct
mutat
cosmc
tabl
cours
indic
altern
pathway
gener
tn
antigen
thu
type
tumor
must
care
examin
distinguish
potenti
pathway
affect
iga
nephropathi
igan
common
primari
glomerulonephr
lead
termin
renal
failur
patient
year
igan
frequent
chines
japanes
popul
rel
rare
person
african
descent
suggest
role
genet
factor
pathogenesi
howev
date
causal
gene
identifi
addit
physiolog
environment
factor
appear
requir
clinic
manifest
diseas
method
unambigu
diagnos
iga
nephropathi
base
renal
biopsi
igan
character
deposit
polymer
iga
mostli
subclass
mesangium
deposit
elicit
glomerular
inflamm
lead
progress
renal
injuri
isol
kidney
iganephropathi
patient
typic
display
galactosedefici
oglycan
hing
region
figur
hing
region
high
content
prolin
serin
threonin
five
olink
glycan
chain
among
nine
potenti
serthr
residu
avail
oglycan
modif
normal
hing
oglycan
consist
core
disaccharid
antigen
carri
one
two
sialic
acid
iga
nephropathi
oglycosyl
includ
express
tn
stn
antigen
possibl
result
bcellrestrict
reduct
tsynthas
activ
whether
cosmc
play
role
pathogenesi
igan
uncertain
sever
studi
suggest
transcript
level
cosmc
tsynthas
reduc
b
cell
patient
igan
studi
link
igan
polymorph
gene
encod
cosmc
tsynthas
yet
anoth
report
conclud
compromis
cosmc
mutat
patient
igan
key
problem
clarifi
role
cosmc
igan
like
minor
fraction
plasma
cell
secret
involv
diseas
identif
isol
popul
plasma
cell
extrem
difficult
crucial
elucid
potenti
role
cosmc
andor
tsynthas
igan
abnorm
glycosyl
hing
region
appear
contribut
pathogenesi
iga
nephropathi
absenc
galactos
termin
galnac
residu
hingeregion
glycopeptid
recogn
natur
occur
igg
antibodi
result
format
circul
immun
complex
therefor
propens
individu
develop
autoimmun
antiglycan
antibodi
may
cofactor
diseas
manifest
altern
aberrantli
glycosyl
hing
region
may
render
molecul
prone
selfaggreg
format
macromolecular
complex
nonimmunolog
mechan
macromolecular
complex
may
escap
hepat
catabol
larg
pass
endotheli
fenestra
reach
hepatocyt
instead
shunt
renal
circul
endotheli
fenestra
overli
glomerular
mesangia
larger
mesangi
cell
bind
highmolecularweight
high
affin
yet
unknown
mechan
activ
mesangi
cell
immun
complex
consid
initi
event
pathogenesi
iga
nephropathi
tn
antigen
express
variou
parasit
first
describ
schistostoma
mansoni
schistosomula
produc
oglycan
consist
simpl
monosaccharidesmostli
oglcnac
also
ogalnac
cestod
echinococcu
granulosu
express
tn
antigen
larval
adult
stage
highest
level
tn
antigen
found
secret
adult
worm
echinococcu
granulosu
caus
diseas
livestock
well
peopl
human
cystic
echinococcosi
chronic
condit
may
prove
fatal
tn
antigen
detect
serum
sampl
affect
patient
role
tn
antigen
parasit
echinococcu
granulosu
determin
howev
antigen
secret
worm
repres
main
immunogen
challeng
host
therefor
like
crucial
determin
whether
success
parasit
establish
cryptosporidium
parvum
waterborn
enter
coccidian
caus
human
anim
diarrheal
diseas
immunocompet
host
infect
asymptomat
andor
selflimit
howev
immunocompromis
patient
may
sever
chronic
fatal
infect
cryptosporidium
occur
oocyst
ingest
food
contamin
water
oocyst
releas
sporozoit
specif
adher
infect
epitheli
cell
small
intestin
infect
depend
mucinlik
glycoprotein
gp
name
express
andor
secret
sporozoit
glycoprotein
found
carri
multipl
olink
agalnac
epitop
appear
crucial
infect
sporozoit
infect
block
galnacspecif
lectin
cryptosporidium
furthermor
express
multival
galgalnacbind
lectin
term
associ
proteincarbohydr
interact
implic
attach
sporozoit
intestin
epitheli
cell
protein
may
form
function
adhes
complex
multival
galgalnacspecif
lectin
may
engag
multipl
interact
parasit
host
carbohydr
therebi
bridg
parasit
host
cell
invas
process
interestingli
shown
antitn
antibodi
block
infect
lymphocyt
human
immunodefici
viru
type
contain
tn
antigen
sever
viralenvelop
glycoprotein
contain
nglycan
also
oglycan
exampl
virus
viral
glycoprotein
contain
oglycan
herp
simplex
viru
type
vaccinia
viru
ha
protein
respiratori
syncyti
viru
mous
hepat
viru
murin
leukemia
viru
coronaviru
hiv
case
hiv
propos
hiv
infect
cell
may
induc
tnantigen
express
potenti
mechan
gener
phenomenon
yet
clear
complic
regard
commonli
use
cell
line
jurkat
express
tn
antigen
glycoprotein
result
defect
synthesi
tsynthas
express
tn
antigen
jurkat
cell
use
target
improv
gene
transfer
tnmediat
endocytosi
antibodycoupl
dna
interestingli
recent
shown
infect
ferret
influenza
viru
caus
upregul
express
sialyltn
antigen
target
tn
antigen
treat
diseas
find
tn
antigen
cell
surfac
neoplast
lesion
encourag
consider
effort
toward
develop
tnantigenbas
antitumor
vaccin
earli
experi
carri
springer
et
al
use
erythrocyt
glycoprotein
antigen
isol
outdat
bank
blood
treat
enzym
expos
tn
antigen
basi
skin
hypersensit
test
reagent
springer
cowork
claim
abl
diagnos
variou
carcinoma
year
biopsi
xray
examin
gave
posit
result
furthermor
springer
cowork
use
prepar
longterm
anticarcinoma
vaccin
report
success
treatment
breast
carcinoma
patient
surviv
year
year
compar
result
standard
pdq
physician
data
queri
data
nation
cancer
institut
claim
probabl
result
fiveyear
surviv
base
chanc
surprisingli
minim
p
even
though
perspect
today
work
springer
cowork
may
pioneer
imposs
judg
valid
data
owe
enigmat
qualiti
erythrocyt
glycoprotein
prepar
nonvalid
diagnost
procedur
lack
multipl
control
nevertheless
attempt
gener
tnantigenbas
vaccin
ongo
result
encourag
contrast
approach
springer
cowork
recent
attempt
gener
vaccin
aim
gener
welldefin
pure
tnantigen
prepar
pure
tn
antigen
isol
natur
sourc
suffici
amount
henc
need
produc
enzymat
andor
chemic
method
product
antibodi
carbohydr
antigen
helper
lymphocyt
need
activ
cooper
b
lymphocyt
gener
carbohydr
alon
howev
activ
helper
lymphocyt
limit
immunogen
therefor
product
vaccin
carbohydr
usual
coupl
carrier
protein
enhanc
present
immun
system
provid
epitop
activ
helper
cell
glycoprotein
process
present
antigenpres
cell
strong
tcell
immun
respons
mount
lead
releas
cytokin
increas
antibodi
respons
antibodi
direct
protein
also
less
immunogen
carbohydr
antigen
may
lead
product
igg
antibodi
class
increas
immunogen
differ
present
tn
antigen
link
protein
keyhol
limpet
haemocyanin
klh
suggest
essenti
immunogen
structur
tn
antigen
cluster
three
four
consecut
monosaccharid
anoth
glycopeptid
vaccin
carri
cluster
tn
antigen
gener
either
chemic
enzymat
transfer
galnac
serthr
residu
peptid
fragment
glycoprotein
overexpress
aberrantli
glycosyl
major
epitheli
cancer
see
also
section
approach
regard
particularli
promis
shown
glycopeptid
consist
three
tandem
repeat
carri
nine
tn
antigen
specif
intern
dendrit
cell
bind
tn
antigen
mgl
receptor
subsequ
glycopeptid
enter
hlai
hlaii
compart
associ
induct
immun
addit
present
sever
cluster
carbohydr
antigen
carrier
peptid
immun
respons
enhanc
coadministr
third
compon
immunolog
adjuv
saponin
sever
threecompon
anticanc
vaccin
advanc
clinic
trial
appear
safe
show
evid
autoimmun
produc
immun
respons
tn
antigen
patient
prostat
cancer
patient
receiv
threecompon
vaccin
tnklh
achiev
favor
respons
measur
decreas
prostatespecif
antigen
psa
slope
whether
decreas
psa
slope
translat
slower
progress
prostat
cancer
improv
surviv
patient
remain
howev
valid
r
cum
et
al
effect
tnantigen
vaccin
clearli
depend
presenc
tn
antigen
carcinoma
cell
surfac
enabl
target
elicit
cell
kill
result
tn
express
prostat
tumor
conflict
use
combin
immunohistochemistri
four
differ
antibodi
carbohydr
microarray
profil
antibodi
li
et
al
recent
found
prostat
tumor
express
tn
antigen
therefor
preselect
patient
tnposit
tumor
may
significantli
increas
success
rate
tnantigen
vaccin
tn
antigen
nonphysiolog
glycan
structur
human
thu
surpris
may
recogn
foreign
immun
system
mgl
express
myeloid
antigenpres
cell
known
specif
bind
termin
aand
blink
galnac
mglposit
antigenpres
cell
found
small
intestin
lymph
node
upon
ligand
bind
mgl
rapidli
intern
endocytos
ligand
transport
along
endosomallysosom
pathway
present
major
histocompat
complex
class
ii
mhc
ii
molecul
mgl
regul
tolllik
receptor
signal
thu
influenc
outcom
immun
respons
depend
whether
addit
dendriticcel
activ
occur
tn
bind
may
lead
either
immun
respons
cell
kill
immun
toler
inhibit
immun
respons
unravel
balanc
immun
respons
toler
tn
antigen
regul
key
understand
pathogen
mechan
underli
tn
syndrom
iga
nephropathi
escap
tnantigenposit
cancer
cell
immunosurveil
also
necessari
design
effect
tnantigenbas
anticanc
vaccin
tn
antigen
though
small
size
simpl
structur
creat
huge
interest
sinc
discoveri
year
ago
appar
biolog
pathophysiolog
tn
antigen
complex
abnorm
express
tn
antigen
human
tissu
associ
patholog
well
express
tn
antigen
human
pathogen
indic
key
target
immun
regul
discoveri
express
tn
antigen
human
anim
patholog
may
result
alter
express
mutat
key
molecular
chaperon
cosmc
regul
tsynthas
fold
creat
new
direct
research
aim
uncov
genet
potenti
epigenet
regul
protein
oglycosyl
howev
much
remain
learn
factor
contribut
patholog
express
tn
antigen
complex
biosynthet
control
prevent
express
normal
cell
new
strategi
aim
creat
vaccin
contain
peptid
conjug
tnstn
antigen
promis
may
lead
effect
therapi
tumor
express
antigen
molecular
strategi
aim
restor
normal
oglycan
express
cell
compromis
oglycan
biosynthesi
might
also
prove
fruit
specif
molecular
target
identifi
dearth
knowledg
howev
normal
function
oglycan
deriv
elong
extens
tn
antigen
knowledg
could
help
defin
patholog
consequ
tn
express
hope
combin
approach
synthet
chemistri
immunolog
cell
biolog
biochemistri
human
anim
genet
lead
breakthrough
defin
structur
function
oglycan
understand
role
tnstn
antigen
diseas
thank
dr
jami
heimburgmolinaro
sandra
cum
help
comment
write
manuscript
work
support
nih
grant
rdc
nih
grant
tj
